Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease

This publication has 51 references indexed in Scilit:

• Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons
  Journal of Comparative Neurology, 1994
• Adenoviral Vector as a Gene Delivery System into Cultured Rat Neuronal and Glial Cells
  European Journal of Neuroscience, 1993
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
  Proceedings of the National Academy of Sciences, 1993
• Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia.
  Proceedings of the National Academy of Sciences, 1992
• Receptor‐mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors
  Journal of Comparative Neurology, 1991
• MPTP-Induced Parkinsonism in Nonhuman Primates
  Published by Elsevier ,1991
• Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF
  Brain Research, 1987
• Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Life Sciences, 1986
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983
• Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
  Journal of the Neurological Sciences, 1973